A Pragmatic Trial on Actions For Collaborative Community Engaged Strategies for HPV

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The present study expands on the investigators' earlier pilot study, outlined in ClinicalTrial ID#: NCT06010108. The Actions for Collaborative Community-Engaged Strategies for HPV (ACCESS-HPV), locally referred to as 4 Girls and Women (4GW) in Nigeria, seek to utilize a participatory crowdsourcing approach to enhance HPV prevention efforts among mother-daughter dyads. Specifically, the investigators aim to 1) develop a new combined HPV vaccination and HPV self-collection campaign for mothers/daughters using crowdsourcing open calls and learning community groups, 2) determine whether the co-developed final combined crowdsourced campaign will increase HPV vaccination rates among girls and promote HPV self-collection among mothers, and 3) estimate the impact and cost-effectiveness of the combined crowdsourced campaign in Nigeria.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 9
Maximum Age: 65
Healthy Volunteers: t
View:

• Female participants

• Aged between 9 and 14 years old for girls/daughters

• Aged between 30 and 65 years old for mothers (mothers defined as any female caregiver, including biological and surrogate mothers or close relatives who meet the eligibility criteria)

• Residing and planning to reside in any of the 18 local government areas for the next 12 months and willing to participate

• Girls must be unvaccinated for HPV.

• Mother must have no recent (at least within 5 years cervical cancer screening)

• Mothers or caregivers must own a mobile phone to follow up with both daughters and mothers.

• Participants must agree to the informed consent in English before enrolling in the study.

Locations
Other Locations
Nigeria
Nigerian Institute of Medical Research
RECRUITING
Yaba
Contact Information
Primary
Juliet Iwelunmor, PhD
ijuliet@wustl.edu
2405280123
Backup
Oliver C Ezechi, MD
oezechi@yahoo.co.uk
Time Frame
Start Date: 2025-02-15
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 1854
Treatments
Experimental: Mother-Daughter Day HPV Campaign
Each of the 18 local government areas begin as part of the control condition and are block-randomized into four waves in the pre-implementation phase, with each wave beginning 2 months after the start of the prior wave and lasting for 6 months. The local government areas will implement the intervention for 6 months, followed by a post implementation phase.
Sponsors
Collaborators: Nigerian Institute of Medical Research, National Cancer Institute (NCI), University of North Carolina, Chapel Hill
Leads: Washington University School of Medicine

This content was sourced from clinicaltrials.gov